Trials / Enrolling By Invitation
Enrolling By InvitationNCT06101979
A Prospective Study of Fortiva in Hernia Repair
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- RTI Surgical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.
Detailed description
This is a post market, prospective, multi-center study of up to 120 participants at approximately 10 clinical study sites. Safety and performance will be measured after hernia repair for two years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fortiva Tissue Matrix | Acellular Dermal Matrix used in hernia surgery |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2023-10-26
- Last updated
- 2025-07-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06101979. Inclusion in this directory is not an endorsement.